| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/22/2013 | CN103119159A Thermophilic mutants of trichoderma reesei endoglucanase I |
| 05/22/2013 | CN103114119A Method for hydrolyzing egg white protein by using protease |
| 05/22/2013 | CN103114118A Method for preparing casein phosphopeptide |
| 05/22/2013 | CN103114117A Method for preparing fish egg sugar protein with anti-osteoporosis effect |
| 05/22/2013 | CN103114116A Method for producing chondroitin sulfate and coproducing peptone, collagen peptide and cartilage calcium powder |
| 05/22/2013 | CN103114115A Method for preparing recombinant human granulocyte colony stimulating factors screened by microorganisms, and medicament composition and preparation thereof |
| 05/22/2013 | CN103113977A Method for synchronously preparing peanut oil and peanut peptides through aqueous enzymatic extraction |
| 05/22/2013 | CN103113496A Clean chitosan production technology |
| 05/22/2013 | CN103113464A Natural human erythropoietin analogue |
| 05/22/2013 | CN103113462A Shark glycoprotein, and preparation method and application thereof |
| 05/22/2013 | CN103110585A Method for preparing spirulina polypeptide-chitosan nano particles |
| 05/22/2013 | CN102718857B Denatured protein powder and brain protein hydrolyzate prepared from same |
| 05/22/2013 | CN102433265B Recombinant strain for producing reduced glutathione and preparation method for recombinant strain |
| 05/22/2013 | CN102251004B Preparation method of royal jelly polypeptide |
| 05/22/2013 | CN102229889B Chlorella, its culture method and applications |
| 05/22/2013 | CN102154420B Method for extracting pigskin collagen peptides |
| 05/22/2013 | CN102140221B Thermoplastic animal protein/plant fiber blend material and preparation method thereof |
| 05/22/2013 | CN101849006B Improved antibody molecule |
| 05/21/2013 | US8448247 Adaptive behavioral intrusion detection systems and methods |
| 05/21/2013 | US8445662 Mycobacterium tuberculosis fusion protein and uses thereof |
| 05/21/2013 | US8445650 Mutant botulinum neurotoxin serotype A polypeptide and uses thereof |
| 05/21/2013 | US8445649 Antibody and use thereof |
| 05/21/2013 | US8445645 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 05/21/2013 | US8445643 Anti-IRC85 monoclonal antibody; and composition comprising the same for preventing and treating tuberculosis or enteritis disease; and the use thereof |
| 05/21/2013 | US8445639 Recombinant bacteriophage and methods for their use |
| 05/21/2013 | US8445634 Method of producing FR901228 |
| 05/21/2013 | US8445446 Unnatural reactive amino acid genetic code additions |
| 05/21/2013 | US8445444 Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 05/21/2013 | US8445425 Urocortin-III and uses thereof |
| 05/21/2013 | US8445283 Methods for producing biological substances in enzyme-deficient mutants of Aspergillus niger |
| 05/21/2013 | US8445237 RNA interference mediating small RNA molecules |
| 05/21/2013 | US8445235 Process for the production of the Actinobacillus pleuropneumoniae toxins APXI or APXIII in a liquid culture medium under supply of air enriched in carbon dioxide |
| 05/21/2013 | US8445234 Methods of making VEGF-D polypeptides |
| 05/21/2013 | US8445233 PGC-1β, a novel PGC-1 homologue and uses therefor |
| 05/21/2013 | US8445232 Cell-free system for synthesis of proteins derived from cultured mammalian cells |
| 05/21/2013 | US8445230 Immunosuppressive polypeptides and nucleic acids |
| 05/21/2013 | US8445228 Enhancement of in vitro translation by nanoparticle conjugates |
| 05/21/2013 | US8445227 N-acetylglucosaminyltransferase III expression in lower eukaryotes |
| 05/21/2013 | US8445223 Anionic acid-labile surfactants and methods of use |
| 05/21/2013 | US8444990 Antibody-induced apoptosis |
| 05/21/2013 | US8444979 Antibodies that inhibit TSLP activity |
| 05/21/2013 | CA2707766C Plasmids ptqomp and ptto-1 which have an ompa signal sequence |
| 05/21/2013 | CA2566101C Novel soluble cd14 antigen |
| 05/21/2013 | CA2468179C Method for producing l-amino acids using bacteria belonging to the genus escherichia |
| 05/21/2013 | CA2460092C A method of diagnosis and treatment and agents useful for same |
| 05/21/2013 | CA2399080C Humanized anti-ccr2 antibodies and methods of use therefor |
| 05/21/2013 | CA2370405C Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof for the production of modified starch |
| 05/21/2013 | CA2305385C Human toll homologues |
| 05/16/2013 | WO2013071112A1 A genetically modified strain of s. cerevisiae engineered to ferment xylose and arabinose |
| 05/16/2013 | WO2013070798A2 Food protein ingredient and methods for producing |
| 05/16/2013 | WO2013070677A1 PmST3 ENZYME FOR CHEMOENZYMATIC SYNTHESIS OF ALPHA-2-3-SIALOSIDES |
| 05/16/2013 | WO2013070615A1 Combination therapies using anti- pseudomonas psl and pcrv binding molecules |
| 05/16/2013 | WO2013069995A1 Preparation method for fermented corn gluten |
| 05/16/2013 | US20130125259 Rna interference mediating small rna molecules |
| 05/16/2013 | US20130123484 Position dependent recognition of gnn nucleotide triplets by zinc fingers |
| 05/16/2013 | US20130123483 Method and device for optimizing a nucelotide sequence for the purpose of expression in a protein |
| 05/16/2013 | US20130122544 Enzyme that catalyzes a peptide-forming reaction from a carboxy component and an amine component, microbe producing the same, and a method of producing a dipeptide using the enzyme or microbe |
| 05/16/2013 | US20130122542 Modified sak gene for the production of recombinant proteins |
| 05/16/2013 | US20130122043 Modified polypeptides and proteins and uses thereof |
| 05/16/2013 | US20130122018 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/16/2013 | US20130121995 Compositions and Methods for Increasing Bone Mineralization |
| 05/16/2013 | DE69132920C5 Methode zur Herstellung von filamentösen, antikörper-präsentierenden Bakteriophagenpartikeln durch Verwendung von Phagemiden und die daduch hergestellten Bakteriophagenpartikel Method for the production of filamentous bacteriophage particles by antibody-presenting use of phagemids and the bacteriophage produced Daduchus |
| 05/16/2013 | CA2855124A1 A genetically modified strain of s. cerevisiae engineered to ferment xylose and arabinose |
| 05/16/2013 | CA2853290A1 Food protein ingredient and methods for producing |
| 05/15/2013 | EP2592137A1 Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use |
| 05/15/2013 | EP2591683A2 Oilseed protein concentrates and isolates, and processes for the production thereof |
| 05/15/2013 | EP2591121A1 Production cell line |
| 05/15/2013 | EP2591101A1 Systems for factor viii processing and methods thereof |
| 05/15/2013 | EP2590671A2 Dual variable domain immunoglobulins and uses thereof |
| 05/15/2013 | CN103103244A Walnut blood pressure-lowering active peptide, its preparation method and application |
| 05/15/2013 | CN103103243A Method for preparing silkworm chrysalis peptide by conducting combined hydrolysis on free enzyme and immobilized enzyme |
| 05/15/2013 | CN103103242A Antioxidant active peptide and preparation method thereof |
| 05/15/2013 | CN103103241A Method for preparing corn oligopeptide by using zein as raw material |
| 05/15/2013 | CN103103240A Strain culture method capable of improving yield of nosiheptide |
| 05/15/2013 | CN103103239A Method for synthesizing thymopentin by enzyme |
| 05/15/2013 | CN103103238A Method of producing polypeptide with selected amino acids antibodies or antibody fragment at specific position in cells |
| 05/15/2013 | CN103103237A Method for cell perfusion culture to produce recombinant protein by microcarrier technology |
| 05/15/2013 | CN103103205A Gene for encoding recombinant porcine circovirus type 2 (PCV2) Cap protein and application of gene |
| 05/15/2013 | CN103102407A Genetic recombinant human-like collagen |
| 05/15/2013 | CN103102396A Novel thiostrepton analog, amd preparation method and application thereof |
| 05/15/2013 | CN102258767B Composition for promoting wound healing |
| 05/15/2013 | CN102051400B Preparation method of yeast mannose glycoprotein product |
| 05/15/2013 | CN101946003B Anti-adam-15 antibodies and utilization of the same |
| 05/15/2013 | CN101609093B Test card for rapid diagnosis of pancreatictrauma and acute pancreatitis and test method thereof |
| 05/15/2013 | CN101255195B Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 05/15/2013 | CN101066999B Recombinant anti-OPN monoclonal antibody and its preparation and use |
| 05/14/2013 | US8440630 Akt activity specifically inhibiting polypeptide |
| 05/14/2013 | US8440627 Chimeric polypeptide; a first domain, a first intracellular loop (i1 loop) or a fragment of a G protein coupled receptor, and a second domain, attached to the first domain, a naturally or non-naturally occurring cell-penetrating, membrane-tethering hydrophobic group |
| 05/14/2013 | US8440451 Genetically modified yeast species, and fermentation processes using genetically modified yeast |
| 05/14/2013 | US8440444 Hybrid enzymes |
| 05/14/2013 | US8440435 Method for reducing 1,2-diglyceride content of an edible oil |
| 05/14/2013 | US8440204 Subtype of Closteridium botulinum neurotoxin type A and uses thereof |
| 05/14/2013 | US8440201 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 05/14/2013 | US8440196 Treatment for pancreatitis using IL-6 receptor antagonist antibodies |
| 05/14/2013 | US8440190 Antibody variants |
| 05/14/2013 | US8440169 Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins |
| 05/14/2013 | CA2506647C Method for digesting proteins highly resistant to denaturation and degradation |
| 05/14/2013 | CA2480561C Method of proliferating human hepatocytes and method of obtaining human hepatocytes |
| 05/14/2013 | CA2478297C Optimizing glycan processing in plants |
| 05/14/2013 | CA2468744C Hybrid antibodies |